Open Access

Immediate reversal of dabigatran with idarucizumab: our clinical experience

Event: ESC CONGRESS 2016
Topic: Atrial fibrillation (AF)
Session type: Satellite Symposium - Experts on the Spot
Sponsored by Boehringer Ingelheim
Date: 28 August 2016
Time: 10:15 - 10:45

Session

1 presentations in this session

Immediate reversal of dabigatran with idarucizumab: our clinical experience.

Speaker: Professor C. Pollack (Atlanta, US)
Speaker: Doctor R. Deo (Philadelphia, US)
Speaker: Associate Professor P. Verhamme (Leuven, BE)
Thumbnail

3 speakers from this session

Professor Charles Pollack

VERO Biotech, Atlanta (United States of America)
4 presentations
0 follower

Doctor Rajat Deo

, Philadelphia (United States of America)
2 presentations
0 follower

Associate Professor Peter Verhamme

Gasthuisberg University Hospital, Leuven (Belgium)
9 presentations
0 follower

This platform is supported by

logo Novo Nordisk